After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Abrupt cuts by the Trump administration to the US National Institutes of Health threaten progress in medical research ...

Josh Brown, CEO of Ritholtz Wealth Management, said during a program on CNBC last month that he’s paying attention to Gilead Sciences Inc (NASDAQ:GILD).

Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market rally that ...

Nearly 15,000 people - including more than 1,500 children - are estimated to have died already because of President Donald Trump and Elon Musk’s savage cuts to USAID, according to an advocacy program ...

Following claims by the National Agency for Food and Drug Administration and Control that the Southeast region accounts for ...

Amref Health Africa, headquartered in Kenya, is often referred to as the largest Africa-based international health and ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...